ID   PRKDC_HUMAN             Reviewed;        4128 AA.
AC   P78527; P78528; Q13327; Q13337; Q14175; Q59H99; Q7Z611; Q96SE6; Q9UME3;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2003, sequence version 3.
DT   12-OCT-2022, entry version 230.
DE   RecName: Full=DNA-dependent protein kinase catalytic subunit;
DE            Short=DNA-PK catalytic subunit;
DE            Short=DNA-PKcs;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:26237645, ECO:0000269|PubMed:32103174, ECO:0000269|PubMed:35460603};
DE   AltName: Full=DNPK1;
DE   AltName: Full=p460;
GN   Name=PRKDC; Synonyms=HYRC, HYRC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=7671312; DOI=10.1016/0092-8674(95)90482-4;
RA   Hartley K.O., Gell D., Smith G.C.M., Zhang H., Divecha N., Connelly M.A.,
RA   Admon A., Lees-Miller S.P., Anderson C.W., Jackson S.P.;
RT   "DNA-dependent protein kinase catalytic subunit: a relative of
RT   phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product.";
RL   Cell 82:849-856(1995).
RN   [2]
RP   SEQUENCE REVISION, AND ALTERNATIVE SPLICING.
RA   Gell D., Anderson C.W.;
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-6; ILE-333; SER-605;
RP   MET-680; SER-695; SER-1071; VAL-1314; VAL-1588; HIS-1603; VAL-2095;
RP   GLU-2702; CYS-2899; ASP-3149; SER-3201; GLU-3404; THR-3434; SER-3459;
RP   MET-3562; LEU-3836 AND VAL-3932.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-1689.
RX   PubMed=11418067; DOI=10.1667/0033-7587(2001)156[0002:fmiptg]2.0.co;2;
RA   Anderson C.W., Dunn J.J., Freimuth P.I., Galloway A.M.,
RA   Allalunis-Turner M.J.;
RT   "Frameshift mutation in PRKDC, the gene for DNA-PKcs, in the DNA repair-
RT   defective, human, glioma-derived cell line M059J.";
RL   Radiat. Res. 156:2-9(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-49.
RX   PubMed=9284934; DOI=10.1159/000134594;
RA   Ladenburger E.M., Fackelmayer F.O., Hameister H., Knippers R.;
RT   "MCM4 and PRKDC, human genes encoding proteins MCM4 and DNA-PKcs, are close
RT   neighbours located on chromosome 8q12-->q13.";
RL   Cytogenet. Cell Genet. 77:268-270(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1789-2203.
RC   TISSUE=Placenta;
RX   PubMed=7638222; DOI=10.1073/pnas.92.16.7515;
RA   Sipley J.D., Menninger J.C., Hartley K.O., Ward D.C., Jackson S.P.,
RA   Anderson C.W.;
RT   "Gene for the catalytic subunit of the human DNA-activated protein kinase
RT   maps to the site of the XRCC7 gene on chromosome 8.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7515-7519(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 2255-2335.
RC   TISSUE=Placenta;
RA   Abe M.;
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3199-4128 (ISOFORM 1).
RC   TISSUE=Fetal lung;
RX   PubMed=7594449;
RA   Poltoratsky V.P., Shi X., York J.D., Lieber M.R., Carter T.H.;
RT   "Human DNA-activated protein kinase (DNA-PK) is homologous to
RT   phosphatidylinositol kinases.";
RL   J. Immunol. 155:4529-4533(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3250-4128 (ISOFORM 1).
RA   Anderson C.W., Dunn J.J., Freimuth P.I.;
RT   "Sequence of the 3' segment (exons 70-86) of PRKDC, the gene for human DNA-
RT   PKcs.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3372-4128 (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno F.R.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   FUNCTION, AND PHOSPHORYLATION OF HSPCA.
RX   PubMed=2507541; DOI=10.1016/s0021-9258(18)71488-9;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "The human double-stranded DNA-activated protein kinase phosphorylates the
RT   90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal threonine
RT   residues.";
RL   J. Biol. Chem. 264:17275-17280(1989).
RN   [12]
RP   FUNCTION, AND PHOSPHORYLATION OF H1.
RX   PubMed=2247066; DOI=10.1128/mcb.10.12.6460-6471.1990;
RA   Carter T., Vancurova I., Sun I., Lou W., DeLeon S.;
RT   "A DNA-activated protein kinase from HeLa cell nuclei.";
RL   Mol. Cell. Biol. 10:6460-6471(1990).
RN   [13]
RP   FUNCTION, AND PHOSPHORYLATION OF MYC.
RX   PubMed=1597196; DOI=10.1111/j.1432-1033.1992.tb16964.x;
RA   Iijima S., Teraoka H., Date T., Tsukada K.;
RT   "DNA-activated protein kinase in Raji Burkitt's lymphoma cells.
RT   Phosphorylation of c-Myc oncoprotein.";
RL   Eur. J. Biochem. 206:595-603(1992).
RN   [14]
RP   FUNCTION, AND PHOSPHORYLATION OF SRF.
RX   PubMed=8407951; DOI=10.1016/s0021-9258(19)36904-2;
RA   Liu S.-H., Ma J.-T., Yueh A.Y., Lees-Miller S.P., Anderson C.W., Ng S.-Y.;
RT   "The carboxyl-terminal transactivation domain of human serum response
RT   factor contains DNA-activated protein kinase phosphorylation sites.";
RL   J. Biol. Chem. 268:21147-21154(1993).
RN   [15]
RP   FUNCTION, AND PHOSPHORYLATION OF JUN.
RX   PubMed=8464713; DOI=10.1093/nar/21.5.1289;
RA   Bannister A.J., Gottlieb T.M., Kouzarides T., Jackson S.P.;
RT   "c-Jun is phosphorylated by the DNA-dependent protein kinase in vitro;
RT   definition of the minimal kinase recognition motif.";
RL   Nucleic Acids Res. 21:1289-1295(1993).
RN   [16]
RP   CLEAVAGE BY CASPASE-3.
RX   PubMed=8804412; DOI=10.1016/0014-5793(96)00842-3;
RA   Teraoka H., Yumoto Y., Watanabe F., Tsukada K., Suwa A., Enari M.,
RA   Nagata S.;
RT   "CPP32/Yama/apopain cleaves the catalytic component of DNA-dependent
RT   protein kinase in the holoenzyme.";
RL   FEBS Lett. 393:1-6(1996).
RN   [17]
RP   ALTERNATIVE SPLICING.
RX   PubMed=8917110; DOI=10.1016/0378-1119(96)00135-7;
RA   Connelly M.A., Zhang H., Kieleczawa J., Anderson C.W.;
RT   "Alternate splice-site utilization in the gene for the catalytic subunit of
RT   the DNA-activated protein kinase, DNA-PKcs.";
RL   Gene 175:271-273(1996).
RN   [18]
RP   FUNCTION, AND PHOSPHORYLATION OF TP53.
RX   PubMed=9363941; DOI=10.1016/s0092-8674(00)80416-x;
RA   Shieh S.-Y., Ikeda M., Taya Y., Prives C.;
RT   "DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.";
RL   Cell 91:325-334(1997).
RN   [19]
RP   CHARACTERIZATION, AND INTERACTION WITH CIB1.
RX   PubMed=9372844; DOI=10.1016/s0921-8777(97)00035-9;
RA   Wu X., Lieber M.R.;
RT   "Interaction between DNA-dependent protein kinase and a novel protein,
RT   KIP.";
RL   Mutat. Res. 385:13-20(1997).
RN   [20]
RP   FUNCTION, AND PHOSPHORYLATION OF XRCC6.
RX   PubMed=9362500; DOI=10.1093/emboj/16.22.6874;
RA   Jin S., Weaver D.T.;
RT   "Double-strand break repair by Ku70 requires heterodimerization with Ku80
RT   and DNA binding functions.";
RL   EMBO J. 16:6874-6885(1997).
RN   [21]
RP   FUNCTION, AND PHOSPHORYLATION OF RFA2.
RX   PubMed=9139719; DOI=10.1074/jbc.272.19.12634;
RA   Niu H., Erdjument-Bromage H., Pan Z.-Q., Lee S.-H., Tempst P., Hurwitz J.;
RT   "Mapping of amino acid residues in the p34 subunit of human single-stranded
RT   DNA-binding protein phosphorylated by DNA-dependent protein kinase and Cdc2
RT   kinase in vitro.";
RL   J. Biol. Chem. 272:12634-12641(1997).
RN   [22]
RP   ACTIVITY REGULATION.
RX   PubMed=9766667;
RA   Sarkaria J.N., Tibbetts R.S., Busby E.C., Kennedy A.P., Hill D.E.,
RA   Abraham R.T.;
RT   "Inhibition of phosphoinositide 3-kinase related kinases by the
RT   radiosensitizing agent wortmannin.";
RL   Cancer Res. 58:4375-4382(1998).
RN   [23]
RP   FUNCTION, INTERACTION WITH C1D, AND MUTAGENESIS OF LEU-1510 AND
RP   1516-GLU-LEU-1517.
RX   PubMed=9679063; DOI=10.1101/gad.12.14.2188;
RA   Yavuzer U., Smith G.C.M., Bliss T., Werner D., Jackson S.P.;
RT   "DNA end-independent activation of DNA-PK mediated via association with the
RT   DNA-binding protein C1D.";
RL   Genes Dev. 12:2188-2199(1998).
RN   [24]
RP   INTERACTION WITH ILF3.
RX   PubMed=9442054; DOI=10.1074/jbc.273.4.2136;
RA   Ting N.S.Y., Kao P.N., Chan D.W., Lintott L.G., Lees-Miller S.P.;
RT   "DNA-dependent protein kinase interacts with antigen receptor response
RT   element binding proteins NF90 and NF45.";
RL   J. Biol. Chem. 273:2136-2145(1998).
RN   [25]
RP   DNA-BINDING.
RX   PubMed=9435225; DOI=10.1073/pnas.95.2.525;
RA   Hammarsten O., Chu G.;
RT   "DNA-dependent protein kinase: DNA binding and activation in the absence of
RT   Ku.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:525-530(1998).
RN   [26]
RP   FUNCTION, AND PHOSPHORYLATION OF XRCC5 AND XRCC6.
RX   PubMed=10026262; DOI=10.1021/bi982584b;
RA   Chan D.W., Ye R., Veillette C.J., Lees-Miller S.P.;
RT   "DNA-dependent protein kinase phosphorylation sites in Ku 70/80
RT   heterodimer.";
RL   Biochemistry 38:1819-1828(1999).
RN   [27]
RP   FUNCTION, AND PHOSPHORYLATION OF PARP1.
RX   PubMed=10467406; DOI=10.1038/sj.onc.1202823;
RA   Ariumi Y., Masutani M., Copeland T.D., Mimori T., Sugimura T.,
RA   Shimotohno K., Ueda K., Hatanaka M., Noda M.;
RT   "Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent
RT   protein kinase in vitro.";
RL   Oncogene 18:4616-4625(1999).
RN   [28]
RP   PHOSPHORYLATION AT THR-2609; SER-2612; THR-2638 AND THR-2647.
RX   PubMed=12186630; DOI=10.1042/bj20020973;
RA   Douglas P., Sapkota G.P., Morrice N., Yu Y., Goodarzi A.A., Merkle D.,
RA   Meek K., Alessi D.R., Lees-Miller S.P.;
RT   "Identification of in vitro and in vivo phosphorylation sites in the
RT   catalytic subunit of the DNA-dependent protein kinase.";
RL   Biochem. J. 368:243-251(2002).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH DCLRE1C.
RX   PubMed=11955432; DOI=10.1016/s0092-8674(02)00671-2;
RA   Ma Y., Pannicke U., Schwarz K., Lieber M.R.;
RT   "Hairpin opening and overhang processing by an Artemis/DNA-dependent
RT   protein kinase complex in nonhomologous end joining and V(D)J
RT   recombination.";
RL   Cell 108:781-794(2002).
RN   [30]
RP   FUNCTION, AND PHOSPHORYLATION OF XRCC4.
RX   PubMed=12509254; DOI=10.1016/s1568-7864(01)00018-0;
RA   Hsu H.-L., Yannone S.M., Chen D.J.;
RT   "Defining interactions between DNA-PK and ligase IV/XRCC4.";
RL   DNA Repair 1:225-235(2002).
RN   [31]
RP   PHOSPHORYLATION AT THR-2609, MUTAGENESIS OF THR-2609, SUBCELLULAR LOCATION,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12231622; DOI=10.1101/gad.1015202;
RA   Chan D.W., Chen B.P., Prithivirajsingh S., Kurimasa A., Story M.D., Qin J.,
RA   Chen D.J.;
RT   "Autophosphorylation of the DNA-dependent protein kinase catalytic subunit
RT   is required for rejoining of DNA double-strand breaks.";
RL   Genes Dev. 16:2333-2338(2002).
RN   [32]
RP   FUNCTION, AND PHOSPHORYLATION OF WRN.
RX   PubMed=11889123; DOI=10.1074/jbc.m111523200;
RA   Karmakar P., Piotrowski J., Brosh R.M. Jr., Sommers J.A., Miller S.P.,
RA   Cheng W.H., Snowden C.M., Ramsden D.A., Bohr V.A.;
RT   "Werner protein is a target of DNA-dependent protein kinase in vivo and in
RT   vitro, and its catalytic activities are regulated by phosphorylation.";
RL   J. Biol. Chem. 277:18291-18302(2002).
RN   [33]
RP   FUNCTION, AND MUTAGENESIS OF THR-2638 AND THR-2647.
RX   PubMed=12649176;
RA   Soubeyrand S., Pope L., Pakuts B., Hache R.J.;
RT   "Threonines 2638/2647 in DNA-PK are essential for cellular resistance to
RT   ionizing radiation.";
RL   Cancer Res. 63:1198-1201(2003).
RN   [34]
RP   FUNCTION, AND PHOSPHORYLATION OF POU2F1.
RX   PubMed=14612514;
RA   Schild-Poulter C., Shih A., Yarymowich N.C., Hache R.J.G.;
RT   "Down-regulation of histone H2B by DNA-dependent protein kinase in response
RT   to DNA damage through modulation of octamer transcription factor 1.";
RL   Cancer Res. 63:7197-7205(2003).
RN   [35]
RP   FUNCTION IN PHOSPHORYLATION OF XRCC4.
RX   PubMed=14599745; DOI=10.1016/s1568-7864(03)00143-5;
RA   Yu Y., Wang W., Ding Q., Ye R., Chen D., Merkle D., Schriemer D., Meek K.,
RA   Lees-Miller S.P.;
RT   "DNA-PK phosphorylation sites in XRCC4 are not required for survival after
RT   radiation or for V(D)J recombination.";
RL   DNA Repair 2:1239-1252(2003).
RN   [36]
RP   FUNCTION, AND PHOSPHORYLATION OF H2AX.
RX   PubMed=14627815; DOI=10.1093/nar/gkg921;
RA   Park E.-J., Chan D.W., Park J.-H., Oettinger M.A., Kwon J.;
RT   "DNA-PK is activated by nucleosomes and phosphorylates H2AX within the
RT   nucleosomes in an acetylation-dependent manner.";
RL   Nucleic Acids Res. 31:6819-6827(2003).
RN   [37]
RP   FUNCTION IN PHOSPHORYLATION OF XRCC4.
RX   PubMed=15177042; DOI=10.1016/j.dnarep.2003.11.005;
RA   Lee K.J., Jovanovic M., Udayakumar D., Bladen C.L., Dynan W.S.;
RT   "Identification of DNA-PKcs phosphorylation sites in XRCC4 and effects of
RT   mutations at these sites on DNA end joining in a cell-free system.";
RL   DNA Repair 3:267-276(2004).
RN   [38]
RP   FUNCTION IN PHOSPHORYLATION OF NHEJ1.
RX   PubMed=18644470; DOI=10.1016/j.dnarep.2008.06.015;
RA   Yu Y., Mahaney B.L., Yano K., Ye R., Fang S., Douglas P., Chen D.J.,
RA   Lees-Miller S.P.;
RT   "DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for
RT   repair of DNA double strand breaks.";
RL   DNA Repair 7:1680-1692(2008).
RN   [39]
RP   FUNCTION IN PHOSPHORYLATION OF XRCC4.
RX   PubMed=26666690; DOI=10.1093/jrr/rrv086;
RA   Sharma M.K., Imamichi S., Fukuchi M., Samarth R.M., Tomita M.,
RA   Matsumoto Y.;
RT   "In cellulo phosphorylation of XRCC4 Ser320 by DNA-PK induced by DNA
RT   damage.";
RL   J. Radiat. Res. 57:115-120(2016).
RN   [40]
RP   FUNCTION IN PHOSPHORYLATION OF XRCC4.
RX   PubMed=30247612; DOI=10.1093/jrr/rry072;
RA   Amiri Moghani A.R., Sharma M.K., Matsumoto Y.;
RT   "In cellulo phosphorylation of DNA double-strand break repair protein XRCC4
RT   on Ser260 by DNA-PK.";
RL   J. Radiat. Res. 59:700-708(2018).
RN   [41]
RP   INTERACTION WITH DCLRE1C.
RX   PubMed=15071507; DOI=10.1038/sj.emboj.7600206;
RA   Pannicke U., Ma Y., Hopfner K.-P., Niewolik D., Lieber M.R., Schwarz K.;
RT   "Functional and biochemical dissection of the structure-specific nuclease
RT   ARTEMIS.";
RL   EMBO J. 23:1987-1997(2004).
RN   [42]
RP   INTERACTION WITH DCLRE1C.
RX   PubMed=14744996; DOI=10.1084/jem.20031142;
RA   Poinsignon C., Moshous D., Callebaut I., de Chasseval R., Villey I.,
RA   de Villartay J.-P.;
RT   "The metallo-beta-lactamase/beta-CASP domain of Artemis constitutes the
RT   catalytic core for V(D)J recombination.";
RL   J. Exp. Med. 199:315-321(2004).
RN   [43]
RP   FUNCTION, AND INTERACTION WITH DCLRE1C.
RX   PubMed=15574326; DOI=10.1016/j.molcel.2004.11.017;
RA   Ma Y., Lu H., Tippin B., Goodman M.F., Shimazaki N., Koiwai O.,
RA   Hsieh C.-L., Schwarz K., Lieber M.R.;
RT   "A biochemically defined system for mammalian nonhomologous DNA end
RT   joining.";
RL   Mol. Cell 16:701-713(2004).
RN   [44]
RP   INTERACTION WITH DCLRE1C.
RX   PubMed=15456891; DOI=10.1128/mcb.24.20.9207-9220.2004;
RA   Zhang X., Succi J., Feng Z., Prithivirajsingh S., Story M.D.,
RA   Legerski R.J.;
RT   "Artemis is a phosphorylation target of ATM and ATR and is involved in the
RT   G2/M DNA damage checkpoint response.";
RL   Mol. Cell. Biol. 24:9207-9220(2004).
RN   [45]
RP   FUNCTION, AND PHOSPHORYLATION OF DHX9.
RX   PubMed=14704337; DOI=10.1093/nar/gkg933;
RA   Zhang S., Schlott B., Goerlach M., Grosse F.;
RT   "DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase
RT   II/RNA helicase A and hnRNP proteins in an RNA-dependent manner.";
RL   Nucleic Acids Res. 32:1-10(2004).
RN   [46]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-2056 AND THR-2609,
RP   AND DEPHOSPHORYLATION AT SER-2056 AND THR-2609.
RX   PubMed=14734805; DOI=10.1073/pnas.0307765100;
RA   Wechsler T., Chen B.P., Harper R., Morotomi-Yano K., Huang B.C., Meek K.,
RA   Cleaver J.E., Chen D.J., Wabl M.;
RT   "DNA-PKcs function regulated specifically by protein phosphatase 5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:1247-1252(2004).
RN   [47]
RP   FUNCTION, AND PHOSPHORYLATION OF H2AX.
RX   PubMed=16046194; DOI=10.1016/j.dnarep.2005.06.005;
RA   Reitsema T., Klokov D., Banath J.P., Olive P.L.;
RT   "DNA-PK is responsible for enhanced phosphorylation of histone H2AX under
RT   hypertonic conditions.";
RL   DNA Repair 4:1172-1181(2005).
RN   [48]
RP   INTERACTION WITH DCLRE1C.
RX   PubMed=15811628; DOI=10.1016/j.dnarep.2005.02.001;
RA   Wang J., Pluth J.M., Cooper P.K., Cowan M.J., Chen D.J., Yannone S.M.;
RT   "Artemis deficiency confers a DNA double-strand break repair defect and
RT   Artemis phosphorylation status is altered by DNA damage and cell cycle
RT   progression.";
RL   DNA Repair 4:556-570(2005).
RN   [49]
RP   INTERACTION WITH DCLRE1C.
RX   PubMed=15936993; DOI=10.1016/j.dnarep.2005.04.013;
RA   Ma Y., Schwarz K., Lieber M.R.;
RT   "The Artemis:DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps.";
RL   DNA Repair 4:845-851(2005).
RN   [50]
RP   INTERACTION WITH XRCC5.
RX   PubMed=15758953; DOI=10.1038/nature03442;
RA   Falck J., Coates J., Jackson S.P.;
RT   "Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA
RT   damage.";
RL   Nature 434:605-611(2005).
RN   [51]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3205, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [52]
RP   FUNCTION, AND PHOSPHORYLATION OF XRCC1.
RX   PubMed=16397295; DOI=10.1093/nar/gkj409;
RA   Levy N., Martz A., Bresson A., Spenlehauer C., de Murcia G.,
RA   Menissier-de Murcia J.;
RT   "XRCC1 is phosphorylated by DNA-dependent protein kinase in response to DNA
RT   damage.";
RL   Nucleic Acids Res. 34:32-41(2006).
RN   [53]
RP   REVIEW.
RX   PubMed=15592499; DOI=10.1038/sj.onc.1208332;
RA   Collis S.J., DeWeese T.L., Jeggo P.A., Parker A.R.;
RT   "The life and death of DNA-PK.";
RL   Oncogene 24:949-961(2005).
RN   [54]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [55]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3205 AND SER-4026, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [56]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3205, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [57]
RP   INVOLVEMENT IN IMD26, AND VARIANT IMD26 ARG-3062.
RX   PubMed=19075392; DOI=10.1172/jci37141;
RA   van der Burg M., Ijspeert H., Verkaik N.S., Turul T., Wiegant W.W.,
RA   Morotomi-Yano K., Mari P.O., Tezcan I., Chen D.J., Zdzienicka M.Z.,
RA   van Dongen J.J., van Gent D.C.;
RT   "A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis
RT   activation and nonhomologous end-joining.";
RL   J. Clin. Invest. 119:91-98(2009).
RN   [58]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-893; SER-2612; SER-3205 AND
RP   SER-4026, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [59]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3205, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [60]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-117; LYS-828; LYS-1209; LYS-1970;
RP   LYS-2259; LYS-3241; LYS-3260; LYS-3621; LYS-3638 AND LYS-3642, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [61]
RP   INTERACTION WITH TTI1.
RX   PubMed=20810650; DOI=10.1101/gad.1934210;
RA   Hurov K.E., Cotta-Ramusino C., Elledge S.J.;
RT   "A genetic screen identifies the Triple T complex required for DNA damage
RT   signaling and ATM and ATR stability.";
RL   Genes Dev. 24:1939-1950(2010).
RN   [62]
RP   INTERACTION WITH TELO2.
RX   PubMed=20801936; DOI=10.1101/gad.1956410;
RA   Takai H., Xie Y., de Lange T., Pavletich N.P.;
RT   "Tel2 structure and function in the Hsp90-dependent maturation of mTOR and
RT   ATR complexes.";
RL   Genes Dev. 24:2019-2030(2010).
RN   [63]
RP   INTERACTION WITH TELO2 AND TTI1.
RX   PubMed=20427287; DOI=10.1074/jbc.m110.121699;
RA   Kaizuka T., Hara T., Oshiro N., Kikkawa U., Yonezawa K., Takehana K.,
RA   Iemura S., Natsume T., Mizushima N.;
RT   "Tti1 and Tel2 are critical factors in mammalian target of rapamycin
RT   complex assembly.";
RL   J. Biol. Chem. 285:20109-20116(2010).
RN   [64]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3205 AND SER-4026, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [65]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [66]
RP   INTERACTION WITH BRAT1, AND PHOSPHORYLATION AT SER-2056.
RX   PubMed=22977523; DOI=10.3892/etm.2011.232;
RA   So E.Y., Ouchi T.;
RT   "Functional interaction of BRCA1/ATM-associated BAAT1 with the DNA-PK
RT   catalytic subunit.";
RL   Exp. Ther. Med. 2:443-447(2011).
RN   [67]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2612 AND SER-3205, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [68]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=22002106; DOI=10.1074/mcp.m111.013680;
RA   Ahmad Y., Boisvert F.M., Lundberg E., Uhlen M., Lamond A.I.;
RT   "Systematic analysis of protein pools, isoforms, and modifications
RT   affecting turnover and subcellular localization.";
RL   Mol. Cell. Proteomics 11:M111.013680.01-M111.013680.15(2012).
RN   [69]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-511; SER-687; SER-841;
RP   SER-1065; THR-2535; SER-2612; THR-2638; THR-2647; SER-2789; SER-3205;
RP   SER-3731; SER-3821 AND SER-4026, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [70]
RP   INTERACTION WITH SETX.
RX   PubMed=23149945; DOI=10.1128/mcb.01195-12;
RA   Yuce O., West S.C.;
RT   "Senataxin, defective in the neurodegenerative disorder ataxia with
RT   oculomotor apraxia 2, lies at the interface of transcription and the DNA
RT   damage response.";
RL   Mol. Cell. Biol. 33:406-417(2013).
RN   [71]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2612, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [72]
RP   UBIQUITINATION BY RNF144A.
RX   PubMed=24979766; DOI=10.1073/pnas.1323107111;
RA   Ho S.R., Mahanic C.S., Lee Y.J., Lin W.C.;
RT   "RNF144A, an E3 ubiquitin ligase for DNA-PKcs, promotes apoptosis during
RT   DNA damage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:E2646-E2655(2014).
RN   [73]
RP   INTERACTION WITH NR4A3.
RX   PubMed=25852083; DOI=10.1093/cvr/cvv126;
RA   Medunjanin S., Daniel J.M., Weinert S., Dutzmann J., Burgbacher F.,
RA   Brecht S., Bruemmer D., Kaehne T., Naumann M., Sedding D.G.,
RA   Zuschratter W., Braun-Dullaeus R.C.;
RT   "DNA-dependent protein kinase (DNA-PK) permits vascular smooth muscle cell
RT   proliferation through phosphorylation of the orphan nuclear receptor
RT   NOR1.";
RL   Cardiovasc. Res. 106:488-497(2015).
RN   [74]
RP   SUBUNIT.
RX   PubMed=25941166; DOI=10.1038/cdd.2015.22;
RA   Craxton A., Somers J., Munnur D., Jukes-Jones R., Cain K., Malewicz M.;
RT   "XLS (c9orf142) is a new component of mammalian DNA double-stranded break
RT   repair.";
RL   Cell Death Differ. 22:890-897(2015).
RN   [75]
RP   FUNCTION IN PHOSPHORYLATION OF FH, AND CATALYTIC ACTIVITY.
RX   PubMed=26237645; DOI=10.1038/ncb3209;
RA   Jiang Y., Qian X., Shen J., Wang Y., Li X., Liu R., Xia Y., Chen Q.,
RA   Peng G., Lin S.Y., Lu Z.;
RT   "Local generation of fumarate promotes DNA repair through inhibition of
RT   histone H3 demethylation.";
RL   Nat. Cell Biol. 17:1158-1168(2015).
RN   [76]
RP   SUBUNIT.
RX   PubMed=25670504; DOI=10.1038/ncomms7233;
RA   Xing M., Yang M., Huo W., Feng F., Wei L., Jiang W., Ning S., Yan Z.,
RA   Li W., Wang Q., Hou M., Dong C., Guo R., Gao G., Ji J., Zha S., Lan L.,
RA   Liang H., Xu D.;
RT   "Interactome analysis identifies a new paralogue of XRCC4 in non-homologous
RT   end joining DNA repair pathway.";
RL   Nat. Commun. 6:6233-6233(2015).
RN   [77]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [78]
RP   INTERACTION WITH PAXX.
RX   PubMed=25574025; DOI=10.1126/science.1261971;
RA   Ochi T., Blackford A.N., Coates J., Jhujh S., Mehmood S., Tamura N.,
RA   Travers J., Wu Q., Draviam V.M., Robinson C.V., Blundell T.L.,
RA   Jackson S.P.;
RT   "DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote
RT   DNA double-strand break repair.";
RL   Science 347:185-188(2015).
RN   [79]
RP   FUNCTION, AND INTERACTION WITH HEXIM1; XRCC5; XRCC6; SFPQ; NONO; PSPC1;
RP   RBM14 AND MATR3.
RX   PubMed=28712728; DOI=10.1016/j.molcel.2017.06.020;
RA   Morchikh M., Cribier A., Raffel R., Amraoui S., Cau J., Severac D.,
RA   Dubois E., Schwartz O., Bennasser Y., Benkirane M.;
RT   "HEXIM1 and NEAT1 Long non-coding RNA form a multi-subunit complex that
RT   regulates DNA-mediated innate immune response.";
RL   Mol. Cell 67:387-399(2017).
RN   [80]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=29478807; DOI=10.1016/j.molcel.2018.01.031;
RA   Huang T.H., Fowler F., Chen C.C., Shen Z.J., Sleckman B., Tyler J.K.;
RT   "The histone chaperones ASF1 and CAF-1 promote MMS22L-TONSL-mediated Rad51
RT   loading onto ssDNA during homologous recombination in human cells.";
RL   Mol. Cell 69:879-892(2018).
RN   [81]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT
RP   THR-2609.
RX   PubMed=32103174; DOI=10.1038/s41586-020-2041-2;
RA   Shao Z., Flynn R.A., Crowe J.L., Zhu Y., Liang J., Jiang W., Aryan F.,
RA   Aoude P., Bertozzi C.R., Estes V.M., Lee B.J., Bhagat G., Zha S., Calo E.;
RT   "DNA-PKcs has KU-dependent function in rRNA processing and
RT   haematopoiesis.";
RL   Nature 579:291-296(2020).
RN   [82]
RP   FUNCTION.
RX   PubMed=33273464; DOI=10.1038/s41467-020-19941-0;
RA   Sun X., Liu T., Zhao J., Xia H., Xie J., Guo Y., Zhong L., Li M., Yang Q.,
RA   Peng C., Rouvet I., Belot A., Shu H.B., Feng P., Zhang J.;
RT   "DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity.";
RL   Nat. Commun. 11:6182-6182(2020).
RN   [83]
RP   INTERACTION WITH KAT5.
RX   PubMed=32832608; DOI=10.1126/sciadv.aba7822;
RA   Gao S.S., Guan H., Yan S., Hu S., Song M., Guo Z.P., Xie D.F., Liu Y.,
RA   Liu X., Zhang S., Zhou P.K.;
RT   "TIP60 K430 SUMOylation attenuates its interaction with DNA-PKcs in S-phase
RT   cells: Facilitating homologous recombination and emerging target for cancer
RT   therapy.";
RL   Sci. Adv. 6:eaba7822-eaba7822(2020).
RN   [84]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=35460603; DOI=10.1016/j.molcel.2022.03.034;
RA   Wang F., Zhao M., Chang B., Zhou Y., Wu X., Ma M., Liu S., Cao Y.,
RA   Zheng M., Dang Y., Xu J., Chen L., Liu T., Tang F., Ren Y., Xu Z., Mao Z.,
RA   Huang K., Luo M., Li J., Liu H., Ge B.;
RT   "Cytoplasmic PARP1 links the genome instability to the inhibition of
RT   antiviral immunity through PARylating cGAS.";
RL   Mol. Cell 0:0-0(2022).
RN   [85] {ECO:0007744|PDB:7LT3}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.6 ANGSTROMS) IN COMPLEX WITH THE NHEJ
RP   COMPLEX, FUNCTION, IDENTIFICATION IN THE NHEJ COMPLEX, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=33854234; DOI=10.1038/s41586-021-03458-7;
RA   Chen S., Lee L., Naila T., Fishbain S., Wang A., Tomkinson A.E.,
RA   Lees-Miller S.P., He Y.;
RT   "Structural basis of long-range to short-range synaptic transition in
RT   NHEJ.";
RL   Nature 593:294-298(2021).
RN   [86]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-6; ASN-263; ILE-333; ILE-420; SER-500;
RP   SER-605; LEU-649; SER-695; HIS-1136; VAL-1190; THR-1237; PHE-1279;
RP   MET-1447; GLY-1619; VAL-1680; VAL-1680; PRO-2023; GLN-2598; ASN-2810;
RP   CYS-2899; ALA-2941; ASP-3085; ASP-3149; SER-3198; SER-3201; GLU-3404;
RP   THR-3434; MET-3562; PHE-3584; ILE-3800; LEU-3836; SER-3936 AND MET-3937.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [87]
RP   VARIANT IMD26 VAL-3574, AND CHARACTERIZATION OF VARIANT IMD26 VAL-3574.
RX   PubMed=23722905; DOI=10.1172/jci67349;
RA   Woodbine L., Neal J.A., Sasi N.K., Shimada M., Deem K., Coleman H.,
RA   Dobyns W.B., Ogi T., Meek K., Davies E.G., Jeggo P.A.;
RT   "PRKDC mutations in a SCID patient with profound neurological
RT   abnormalities.";
RL   J. Clin. Invest. 123:2969-2980(2013).
CC   -!- FUNCTION: Serine/threonine-protein kinase that acts as a molecular
CC       sensor for DNA damage (PubMed:11955432, PubMed:12649176,
CC       PubMed:14734805, PubMed:33854234). Involved in DNA non-homologous end
CC       joining (NHEJ) required for double-strand break (DSB) repair and V(D)J
CC       recombination (PubMed:11955432, PubMed:12649176, PubMed:14734805,
CC       PubMed:33854234). Must be bound to DNA to express its catalytic
CC       properties (PubMed:11955432). Promotes processing of hairpin DNA
CC       structures in V(D)J recombination by activation of the hairpin
CC       endonuclease artemis (DCLRE1C) (PubMed:11955432). Recruited by XRCC5
CC       and XRCC6 to DNA ends and is required to (1) protect and align broken
CC       ends of DNA, thereby preventing their degradation, (2) and sequester
CC       the DSB for repair by NHEJ (PubMed:15574326, PubMed:11955432,
CC       PubMed:12649176, PubMed:14734805, PubMed:33854234). Act as a scaffold
CC       protein to aid the localization of DNA repair proteins to the site of
CC       damage (PubMed:15574326, PubMed:11955432, PubMed:12649176,
CC       PubMed:14734805). The assembly of the DNA-PK complex at DNA ends is
CC       also required for the NHEJ ligation step (PubMed:15574326,
CC       PubMed:11955432, PubMed:12649176, PubMed:14734805). Found at the ends
CC       of chromosomes, suggesting a further role in the maintenance of
CC       telomeric stability and the prevention of chromosomal end fusion (By
CC       similarity). Also involved in modulation of transcription
CC       (PubMed:15574326, PubMed:11955432, PubMed:12649176, PubMed:14734805).
CC       As part of the DNA-PK complex, involved in the early steps of ribosome
CC       assembly by promoting the processing of precursor rRNA into mature 18S
CC       rRNA in the small-subunit processome (PubMed:32103174). Binding to U3
CC       small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit
CC       processome (PubMed:32103174). Recognizes the substrate consensus
CC       sequence [ST]-Q (PubMed:15574326, PubMed:11955432, PubMed:12649176,
CC       PubMed:14734805). Phosphorylates 'Ser-139' of histone variant H2AX,
CC       thereby regulating DNA damage response mechanism (PubMed:14627815,
CC       PubMed:16046194). Phosphorylates ASF1A, DCLRE1C, c-Abl/ABL1, histone
CC       H1, HSPCA, c-jun/JUN, p53/TP53, PARP1, POU2F1, DHX9, FH, SRF,
CC       NHEJ1/XLF, XRCC1, XRCC4, XRCC5, XRCC6, WRN, MYC and RFA2
CC       (PubMed:2507541, PubMed:2247066, PubMed:1597196, PubMed:8407951,
CC       PubMed:8464713, PubMed:9362500, PubMed:9139719, PubMed:10026262,
CC       PubMed:10467406, PubMed:12509254, PubMed:11889123, PubMed:14612514,
CC       PubMed:14599745, PubMed:15177042, PubMed:18644470, PubMed:26666690,
CC       PubMed:30247612, PubMed:14704337, PubMed:16397295, PubMed:26237645,
CC       PubMed:28712728, PubMed:29478807). Can phosphorylate C1D not only in
CC       the presence of linear DNA but also in the presence of supercoiled DNA
CC       (PubMed:9679063). Ability to phosphorylate p53/TP53 in the presence of
CC       supercoiled DNA is dependent on C1D (PubMed:9363941). Contributes to
CC       the determination of the circadian period length by antagonizing
CC       phosphorylation of CRY1 'Ser-588' and increasing CRY1 protein
CC       stability, most likely through an indirect mechanism (By similarity).
CC       Plays a role in the regulation of DNA virus-mediated innate immune
CC       response by assembling into the HDP-RNP complex, a complex that serves
CC       as a platform for IRF3 phosphorylation and subsequent innate immune
CC       response activation through the cGAS-STING pathway (PubMed:28712728).
CC       Also regulates the cGAS-STING pathway by catalyzing phosphorylation of
CC       CGAS, thereby impairing CGAS oligomerization and activation
CC       (PubMed:33273464). Also regulates the cGAS-STING pathway by mediating
CC       phosphorylation of PARP1 (PubMed:35460603).
CC       {ECO:0000250|UniProtKB:P97313, ECO:0000269|PubMed:10026262,
CC       ECO:0000269|PubMed:10467406, ECO:0000269|PubMed:11889123,
CC       ECO:0000269|PubMed:11955432, ECO:0000269|PubMed:12509254,
CC       ECO:0000269|PubMed:12649176, ECO:0000269|PubMed:14599745,
CC       ECO:0000269|PubMed:14612514, ECO:0000269|PubMed:14627815,
CC       ECO:0000269|PubMed:14704337, ECO:0000269|PubMed:14734805,
CC       ECO:0000269|PubMed:15177042, ECO:0000269|PubMed:15574326,
CC       ECO:0000269|PubMed:1597196, ECO:0000269|PubMed:16046194,
CC       ECO:0000269|PubMed:16397295, ECO:0000269|PubMed:18644470,
CC       ECO:0000269|PubMed:2247066, ECO:0000269|PubMed:2507541,
CC       ECO:0000269|PubMed:26237645, ECO:0000269|PubMed:26666690,
CC       ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:29478807,
CC       ECO:0000269|PubMed:30247612, ECO:0000269|PubMed:32103174,
CC       ECO:0000269|PubMed:33273464, ECO:0000269|PubMed:33854234,
CC       ECO:0000269|PubMed:35460603, ECO:0000269|PubMed:8407951,
CC       ECO:0000269|PubMed:8464713, ECO:0000269|PubMed:9139719,
CC       ECO:0000269|PubMed:9362500, ECO:0000269|PubMed:9363941,
CC       ECO:0000269|PubMed:9679063}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:29478807, ECO:0000269|PubMed:32103174};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990;
CC         Evidence={ECO:0000269|PubMed:29478807, ECO:0000269|PubMed:32103174};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:26237645,
CC         ECO:0000269|PubMed:32103174, ECO:0000269|PubMed:35460603};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609;
CC         Evidence={ECO:0000269|PubMed:26237645, ECO:0000269|PubMed:32103174,
CC         ECO:0000269|PubMed:35460603};
CC   -!- ACTIVITY REGULATION: Activity seems to be attenuated by
CC       autophosphorylation. Binding to the SL1 region of U3 small nucleolar
CC       RNA promotes auto-phosphorylation activity (PubMed:32103174). Inhibited
CC       by wortmannin (PubMed:9766667). {ECO:0000269|PubMed:32103174,
CC       ECO:0000269|PubMed:9766667}.
CC   -!- SUBUNIT: DNA-PK is a heterotrimer of PRKDC and the Ku dimer (composed
CC       of XRCC6/Ku70 and XRCC5/Ku86) (PubMed:15758953, PubMed:25670504).
CC       Formation of this complex may be promoted by interaction with ILF3
CC       (PubMed:9442054). Component of the core long-range non-homologous end
CC       joining (NHEJ) complex (also named DNA-PK complex) composed of PRKDC,
CC       LIG4, XRCC4, XRCC6/Ku70, XRCC5/Ku86 and NHEJ1/XLF (PubMed:15758953,
CC       PubMed:25670504, PubMed:33854234). Additional component of the NHEJ
CC       complex includes PAXX (PubMed:25574025, PubMed:25941166). Following
CC       autophosphorylation, PRKDC dissociates from DNA (PubMed:33854234).
CC       Interacts with DNA-PKcs-interacting protein (KIP) with the region
CC       upstream the kinase domain (PubMed:9372844). PRKDC alone also interacts
CC       with and phosphorylates DCLRE1C, thereby activating the latent
CC       endonuclease activity of this protein (PubMed:11955432,
CC       PubMed:15071507, PubMed:14744996, PubMed:15456891, PubMed:15574326,
CC       PubMed:15811628, PubMed:15936993). Interacts with C1D (PubMed:9679063).
CC       Interacts with TTI1 and TELO2 (PubMed:20801936, PubMed:20427287,
CC       PubMed:20810650). Interacts with CIB1 (PubMed:9372844). Interacts with
CC       SETX (PubMed:23149945). Interacts with NR4A3; the DNA-dependent protein
CC       kinase complex DNA-PK phosphorylates and activates NR4A3 and prevents
CC       NR4A3 ubiquitination and degradation (PubMed:25852083). Interacts with
CC       BRAT1 (PubMed:22977523). Part of the HDP-RNP complex composed of at
CC       least HEXIM1, PRKDC, XRCC5, XRCC6, paraspeckle proteins (SFPQ, NONO,
CC       PSPC1, RBM14, and MATR3) and NEAT1 RNA (PubMed:28712728). Interacts
CC       with KAT5 (PubMed:32832608). {ECO:0000269|PubMed:11955432,
CC       ECO:0000269|PubMed:14744996, ECO:0000269|PubMed:15071507,
CC       ECO:0000269|PubMed:15456891, ECO:0000269|PubMed:15574326,
CC       ECO:0000269|PubMed:15758953, ECO:0000269|PubMed:15811628,
CC       ECO:0000269|PubMed:15936993, ECO:0000269|PubMed:20427287,
CC       ECO:0000269|PubMed:20801936, ECO:0000269|PubMed:20810650,
CC       ECO:0000269|PubMed:22977523, ECO:0000269|PubMed:23149945,
CC       ECO:0000269|PubMed:25574025, ECO:0000269|PubMed:25670504,
CC       ECO:0000269|PubMed:25852083, ECO:0000269|PubMed:25941166,
CC       ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:32832608,
CC       ECO:0000269|PubMed:33854234, ECO:0000269|PubMed:9372844,
CC       ECO:0000269|PubMed:9442054, ECO:0000269|PubMed:9679063}.
CC   -!- INTERACTION:
CC       P78527; O43918: AIRE; NbExp=2; IntAct=EBI-352053, EBI-1753081;
CC       P78527; P10275: AR; NbExp=3; IntAct=EBI-352053, EBI-608057;
CC       P78527; Q96SD1: DCLRE1C; NbExp=4; IntAct=EBI-352053, EBI-11694104;
CC       P78527; P14921: ETS1; NbExp=2; IntAct=EBI-352053, EBI-913209;
CC       P78527; P50549: ETV1; NbExp=2; IntAct=EBI-352053, EBI-3905068;
CC       P78527; P09629: HOXB7; NbExp=2; IntAct=EBI-352053, EBI-1248457;
CC       P78527; Q9BPZ7: MAPKAP1; NbExp=2; IntAct=EBI-352053, EBI-749938;
CC       P78527; Q96RI1-2: NR1H4; NbExp=4; IntAct=EBI-352053, EBI-9640524;
CC       P78527; P10276: RARA; NbExp=3; IntAct=EBI-352053, EBI-413374;
CC       P78527; P17947: SPI1; NbExp=2; IntAct=EBI-352053, EBI-2293548;
CC       P78527; P13010: XRCC5; NbExp=8; IntAct=EBI-352053, EBI-357997;
CC       P78527; P12956: XRCC6; NbExp=7; IntAct=EBI-352053, EBI-353208;
CC       P78527; P25490: YY1; NbExp=2; IntAct=EBI-352053, EBI-765538;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12231622,
CC       ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:22002106}. Nucleus,
CC       nucleolus {ECO:0000269|PubMed:22002106, ECO:0000269|PubMed:32103174}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P78527-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78527-2; Sequence=VSP_004708;
CC   -!- PTM: Autophosphorylated at two clusters, the T2609 cluster and the
CC       S2056 cluster (PubMed:33854234). Autophosphorylated on Ser-2056, Thr-
CC       2609, Thr-2638 and Thr-2647 (PubMed:14734805, PubMed:12186630,
CC       PubMed:12231622, PubMed:33854234). Ser-2056 and Thr-2609 are DNA
CC       damage-inducible phosphorylation sites (inducible with ionizing
CC       radiation, IR) dephosphorylated by PPP5C (PubMed:14734805,
CC       PubMed:12186630, PubMed:12231622). Autophosphorylation induces a
CC       conformational change that leads to remodeling of the DNA-PK complex,
CC       requisite for efficient end processing and DNA repair (PubMed:14734805,
CC       PubMed:12186630, PubMed:12231622). Autophosphorylation in trans within
CC       DNA-PK complexes loaded on DNA ends leads to the dissociation of PRKDC
CC       from DNA and the transition into the short-range NHEJ complex
CC       (PubMed:33854234). Autophosphorylation of the T2609 cluster is required
CC       for hematopoietic development and protein synthesis in erythrocytes
CC       precursors (By similarity). {ECO:0000250|UniProtKB:P97313,
CC       ECO:0000269|PubMed:12186630, ECO:0000269|PubMed:12231622,
CC       ECO:0000269|PubMed:14734805, ECO:0000269|PubMed:33854234}.
CC   -!- PTM: S-nitrosylated by GAPDH. {ECO:0000250|UniProtKB:P97313}.
CC   -!- PTM: Polyubiquitinated by RNF144A, leading to proteasomal degradation.
CC       {ECO:0000269|PubMed:24979766}.
CC   -!- DISEASE: Immunodeficiency 26 with or without neurologic abnormalities
CC       (IMD26) [MIM:615966]: A form of severe combined immunodeficiency
CC       characterized by reduced or absent T and B cells, recurrent
CC       candidiasis, and lower respiratory tract infections. Some patients show
CC       dysmorphic features, severe growth failure, microcephaly, seizures, and
CC       impaired neurological functions. {ECO:0000269|PubMed:19075392,
CC       ECO:0000269|PubMed:23722905}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/prkdc/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U47077; AAB39925.5; -; mRNA.
DR   EMBL; U34994; AAC50210.3; -; mRNA.
DR   EMBL; AY316117; AAP69525.1; -; Genomic_DNA.
DR   EMBL; U63630; AAC52019.2; -; Genomic_DNA.
DR   EMBL; U90415; AAB51722.1; -; Genomic_DNA.
DR   EMBL; L27425; AAA79244.1; -; Genomic_DNA.
DR   EMBL; AB052953; BAB79635.1; -; Genomic_DNA.
DR   EMBL; U35835; AAA79184.1; -; mRNA.
DR   EMBL; AY030284; AAK40350.1; -; Genomic_DNA.
DR   EMBL; AB208860; BAD92097.1; -; mRNA.
DR   CCDS; CCDS75734.1; -. [P78527-2]
DR   CCDS; CCDS75735.1; -. [P78527-1]
DR   PIR; A57099; A57099.
DR   PIR; G02083; G02083.
DR   RefSeq; NP_001075109.1; NM_001081640.1. [P78527-2]
DR   RefSeq; NP_008835.5; NM_006904.6. [P78527-1]
DR   PDB; 5LUQ; X-ray; 4.30 A; A/B=2-2575, A/B=2774-4127.
DR   PDB; 5W1R; EM; 4.40 A; A=1-4128.
DR   PDB; 5Y3R; EM; 6.60 A; C=10-4128.
DR   PDB; 6ZFP; EM; 3.24 A; A=1-4128.
DR   PDB; 6ZH2; EM; 3.92 A; A=1-4128.
DR   PDB; 6ZH4; EM; 3.62 A; A=1-4128.
DR   PDB; 6ZH6; EM; 3.93 A; A=1-4128.
DR   PDB; 6ZH8; EM; 4.14 A; A=1-4128.
DR   PDB; 6ZHA; EM; 3.91 A; A=1-4128.
DR   PDB; 6ZHE; EM; 7.24 A; A/F=1-4128.
DR   PDB; 7K0Y; EM; 3.70 A; A=1-4128.
DR   PDB; 7K10; EM; 3.30 A; A=1-4128.
DR   PDB; 7K11; EM; 3.21 A; A=1-4128.
DR   PDB; 7K19; EM; 4.30 A; A=1-4128.
DR   PDB; 7K1B; EM; 4.30 A; A=1-4128.
DR   PDB; 7K1J; EM; 3.90 A; A=1-4128.
DR   PDB; 7K1K; EM; 4.10 A; A=1-4128.
DR   PDB; 7K1N; EM; 3.90 A; A=1-4128.
DR   PDB; 7LT3; EM; 4.60 A; C/L=1-4128.
DR   PDB; 7NFC; EM; 4.14 A; A/F=1-4128.
DR   PDB; 7NFE; EM; 4.29 A; A=1-4128.
DR   PDB; 7OTM; EM; 3.33 A; A=1-4128.
DR   PDB; 7OTP; EM; 3.40 A; A=1-4128.
DR   PDB; 7OTV; EM; 3.24 A; A=1-4128.
DR   PDB; 7OTW; EM; 2.99 A; A=1-4128.
DR   PDB; 7OTY; EM; 2.96 A; A=1-4128.
DR   PDB; 7SGL; EM; 3.00 A; A=1-4128.
DR   PDB; 7SU3; EM; 3.30 A; A=1-4128.
DR   PDB; 7SUD; EM; 3.60 A; A=1-4128.
DR   PDBsum; 5LUQ; -.
DR   PDBsum; 5W1R; -.
DR   PDBsum; 5Y3R; -.
DR   PDBsum; 6ZFP; -.
DR   PDBsum; 6ZH2; -.
DR   PDBsum; 6ZH4; -.
DR   PDBsum; 6ZH6; -.
DR   PDBsum; 6ZH8; -.
DR   PDBsum; 6ZHA; -.
DR   PDBsum; 6ZHE; -.
DR   PDBsum; 7K0Y; -.
DR   PDBsum; 7K10; -.
DR   PDBsum; 7K11; -.
DR   PDBsum; 7K19; -.
DR   PDBsum; 7K1B; -.
DR   PDBsum; 7K1J; -.
DR   PDBsum; 7K1K; -.
DR   PDBsum; 7K1N; -.
DR   PDBsum; 7LT3; -.
DR   PDBsum; 7NFC; -.
DR   PDBsum; 7NFE; -.
DR   PDBsum; 7OTM; -.
DR   PDBsum; 7OTP; -.
DR   PDBsum; 7OTV; -.
DR   PDBsum; 7OTW; -.
DR   PDBsum; 7OTY; -.
DR   PDBsum; 7SGL; -.
DR   PDBsum; 7SU3; -.
DR   PDBsum; 7SUD; -.
DR   SASBDB; P78527; -.
DR   SMR; P78527; -.
DR   BioGRID; 111577; 563.
DR   ComplexPortal; CPX-3403; DNA-dependent protein kinase complex.
DR   CORUM; P78527; -.
DR   DIP; DIP-24186N; -.
DR   ELM; P78527; -.
DR   IntAct; P78527; 228.
DR   MINT; P78527; -.
DR   STRING; 9606.ENSP00000313420; -.
DR   BindingDB; P78527; -.
DR   ChEMBL; CHEMBL3142; -.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB05210; SF1126.
DR   DrugCentral; P78527; -.
DR   GuidetoPHARMACOLOGY; 2800; -.
DR   CarbonylDB; P78527; -.
DR   GlyConnect; 1183; 1 N-Linked glycan (1 site).
DR   GlyGen; P78527; 9 sites, 1 N-linked glycan (1 site), 2 O-linked glycans (8 sites).
DR   iPTMnet; P78527; -.
DR   MetOSite; P78527; -.
DR   PhosphoSitePlus; P78527; -.
DR   SwissPalm; P78527; -.
DR   BioMuta; PRKDC; -.
DR   DMDM; 38258929; -.
DR   SWISS-2DPAGE; P78527; -.
DR   EPD; P78527; -.
DR   jPOST; P78527; -.
DR   MassIVE; P78527; -.
DR   MaxQB; P78527; -.
DR   PaxDb; P78527; -.
DR   PeptideAtlas; P78527; -.
DR   PRIDE; P78527; -.
DR   ProteomicsDB; 57634; -. [P78527-1]
DR   ProteomicsDB; 57635; -. [P78527-2]
DR   Antibodypedia; 52433; 1584 antibodies from 43 providers.
DR   DNASU; 5591; -.
DR   Ensembl; ENST00000314191.7; ENSP00000313420.3; ENSG00000253729.8. [P78527-1]
DR   Ensembl; ENST00000338368.7; ENSP00000345182.4; ENSG00000253729.8. [P78527-2]
DR   GeneID; 5591; -.
DR   KEGG; hsa:5591; -.
DR   MANE-Select; ENST00000314191.7; ENSP00000313420.3; NM_006904.7; NP_008835.5.
DR   UCSC; uc033bkh.1; human. [P78527-1]
DR   CTD; 5591; -.
DR   DisGeNET; 5591; -.
DR   GeneCards; PRKDC; -.
DR   HGNC; HGNC:9413; PRKDC.
DR   HPA; ENSG00000253729; Low tissue specificity.
DR   MalaCards; PRKDC; -.
DR   MIM; 600899; gene.
DR   MIM; 615966; phenotype.
DR   neXtProt; NX_P78527; -.
DR   OpenTargets; ENSG00000253729; -.
DR   Orphanet; 317425; Severe combined immunodeficiency due to DNA-PKcs deficiency.
DR   PharmGKB; PA33776; -.
DR   VEuPathDB; HostDB:ENSG00000253729; -.
DR   eggNOG; KOG0891; Eukaryota.
DR   GeneTree; ENSGT00940000155633; -.
DR   HOGENOM; CLU_224534_0_0_1; -.
DR   InParanoid; P78527; -.
DR   OMA; GIQIFMQ; -.
DR   OrthoDB; 26975at2759; -.
DR   PhylomeDB; P78527; -.
DR   TreeFam; TF324494; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; P78527; -.
DR   Reactome; R-HSA-1834949; Cytosolic sensors of pathogen-associated DNA.
DR   Reactome; R-HSA-3270619; IRF3-mediated induction of type I IFN.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   SignaLink; P78527; -.
DR   SIGNOR; P78527; -.
DR   BioGRID-ORCS; 5591; 63 hits in 314 CRISPR screens.
DR   ChiTaRS; PRKDC; human.
DR   GeneWiki; DNA-PKcs; -.
DR   GenomeRNAi; 5591; -.
DR   Pharos; P78527; Tchem.
DR   PRO; PR:P78527; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; P78527; protein.
DR   Bgee; ENSG00000253729; Expressed in ventricular zone and 204 other tissues.
DR   ExpressionAtlas; P78527; baseline and differential.
DR   Genevisible; P78527; HS.
DR   GO; GO:0000781; C:chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070418; C:DNA-dependent protein kinase complex; IPI:ComplexPortal.
DR   GO; GO:0005958; C:DNA-dependent protein kinase-DNA ligase 4 complex; IDA:MGI.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0070419; C:nonhomologous end joining complex; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IMP:CAFA.
DR   GO; GO:0032993; C:protein-DNA complex; IDA:CAFA.
DR   GO; GO:0032040; C:small-subunit processome; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004677; F:DNA-dependent protein kinase activity; IDA:MGI.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:CAFA.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0004672; F:protein kinase activity; IDA:CACAO.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0034511; F:U3 snoRNA binding; IDA:UniProtKB.
DR   GO; GO:0002218; P:activation of innate immune response; IDA:UniProtKB.
DR   GO; GO:0002326; P:B cell lineage commitment; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL.
DR   GO; GO:0006302; P:double-strand break repair; IMP:BHF-UCL.
DR   GO; GO:0097681; P:double-strand break repair via alternative nonhomologous end joining; TAS:BHF-UCL.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
DR   GO; GO:0035234; P:ectopic germ cell programmed cell death; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0002327; P:immature B cell differentiation; IEA:Ensembl.
DR   GO; GO:0033152; P:immunoglobulin V(D)J recombination; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IBA:GO_Central.
DR   GO; GO:0000460; P:maturation of 5.8S rRNA; IDA:UniProtKB.
DR   GO; GO:0031571; P:mitotic G1 DNA damage checkpoint signaling; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:CACAO.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:2001034; P:positive regulation of double-strand break repair via nonhomologous end joining; IDA:UniProtKB.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0045621; P:positive regulation of lymphocyte differentiation; ISS:UniProtKB.
DR   GO; GO:1905221; P:positive regulation of platelet formation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0045727; P:positive regulation of translation; ISS:UniProtKB.
DR   GO; GO:0002328; P:pro-B cell differentiation; IEA:Ensembl.
DR   GO; GO:0031648; P:protein destabilization; IEA:Ensembl.
DR   GO; GO:0036211; P:protein modification process; TAS:ProtInc.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0050678; P:regulation of epithelial cell proliferation; IMP:BHF-UCL.
DR   GO; GO:1902036; P:regulation of hematopoietic stem cell differentiation; ISS:UniProtKB.
DR   GO; GO:0048660; P:regulation of smooth muscle cell proliferation; IMP:UniProtKB.
DR   GO; GO:0010332; P:response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0034462; P:small-subunit processome assembly; IDA:UniProtKB.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   GO; GO:0033077; P:T cell differentiation in thymus; IEA:Ensembl.
DR   GO; GO:0002360; P:T cell lineage commitment; IEA:Ensembl.
DR   GO; GO:0033153; P:T cell receptor V(D)J recombination; IEA:Ensembl.
DR   GO; GO:0016233; P:telomere capping; IMP:BHF-UCL.
DR   GO; GO:0000723; P:telomere maintenance; IBA:GO_Central.
DR   CDD; cd05172; PIKKc_DNA-PK; 1.
DR   Gene3D; 1.10.1070.11; -; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR037706; DNA-PK_dom.
DR   InterPro; IPR012582; DNAPKcs_CC3.
DR   InterPro; IPR045581; DNAPKcs_CC5.
DR   InterPro; IPR003152; FATC_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR036940; PI3/4_kinase_cat_sf.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR003151; PIK-rel_kinase_FAT.
DR   InterPro; IPR014009; PIK_FAT.
DR   Pfam; PF19704; DNAPKcs_CC5; 1.
DR   Pfam; PF02259; FAT; 1.
DR   Pfam; PF02260; FATC; 1.
DR   Pfam; PF08163; NUC194; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   SMART; SM01343; FATC; 1.
DR   SMART; SM01344; NUC194; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SUPFAM; SSF48371; SSF48371; 3.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51189; FAT; 1.
DR   PROSITE; PS51190; FATC; 1.
DR   PROSITE; PS00915; PI3_4_KINASE_1; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Biological rhythms; Disease variant; DNA damage; DNA recombination;
KW   DNA repair; DNA-binding; Immunity; Innate immunity; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Ribosome biogenesis; SCID; Serine/threonine-protein kinase; TPR repeat;
KW   Transferase; Ubl conjugation.
FT   CHAIN           1..4128
FT                   /note="DNA-dependent protein kinase catalytic subunit"
FT                   /id="PRO_0000225598"
FT   REPEAT          288..323
FT                   /note="HEAT 1"
FT   REPEAT          1004..1040
FT                   /note="HEAT 2"
FT   REPEAT          1723..1756
FT                   /note="TPR 1"
FT   DOMAIN          2906..3539
FT                   /note="FAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00534"
FT   REPEAT          2920..2948
FT                   /note="TPR 2"
FT   REPEAT          2949..2982
FT                   /note="TPR 3"
FT   DOMAIN          3722..4053
FT                   /note="PI3K/PI4K catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   DOMAIN          4096..4128
FT                   /note="FATC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00534,
FT                   ECO:0000255|PROSITE-ProRule:PRU00535"
FT   REGION          1503..1538
FT                   /note="Interaction with C1D"
FT                   /evidence="ECO:0000269|PubMed:9679063"
FT   REGION          1503..1538
FT                   /note="Leucine-zipper"
FT   REGION          2050..2073
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2436..3212
FT                   /note="KIP-binding"
FT                   /evidence="ECO:0000269|PubMed:9372844"
FT   REGION          3200..3222
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          3728..3734
FT                   /note="G-loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          3919..3927
FT                   /note="Catalytic loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          3939..3964
FT                   /note="Activation loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   SITE            2020..2021
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000269|PubMed:8804412"
FT   MOD_RES         117
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         511
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         687
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         828
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         841
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         893
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         1065
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1209
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         1970
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         2056
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:14734805,
FT                   ECO:0000269|PubMed:22977523"
FT   MOD_RES         2259
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         2535
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         2609
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:12186630,
FT                   ECO:0000269|PubMed:12231622, ECO:0000269|PubMed:14734805,
FT                   ECO:0000269|PubMed:32103174"
FT   MOD_RES         2612
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:12186630,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         2638
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:12186630,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         2647
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:12186630,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         2789
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         3205
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         3241
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         3260
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         3621
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         3638
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         3642
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         3731
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         3821
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         4026
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         3799..3829
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.10"
FT                   /id="VSP_004708"
FT   VARIANT         6
FT                   /note="A -> S (in dbSNP:rs8177999)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019179"
FT   VARIANT         263
FT                   /note="K -> N (in a lung adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs758032015)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041602"
FT   VARIANT         333
FT                   /note="M -> I (in dbSNP:rs8178017)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019180"
FT   VARIANT         420
FT                   /note="V -> I (in dbSNP:rs55925466)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041603"
FT   VARIANT         500
FT                   /note="G -> S (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041604"
FT   VARIANT         605
FT                   /note="T -> S (in dbSNP:rs8178033)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019181"
FT   VARIANT         649
FT                   /note="F -> L (in dbSNP:rs55811715)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041605"
FT   VARIANT         680
FT                   /note="I -> M (in dbSNP:rs8178040)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019182"
FT   VARIANT         695
FT                   /note="P -> S (in dbSNP:rs8178046)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019183"
FT   VARIANT         1071
FT                   /note="N -> S (in dbSNP:rs8178070)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019184"
FT   VARIANT         1136
FT                   /note="R -> H (in a colorectal adenocarcinoma sample;
FT                   somatic mutation; dbSNP:rs781401034)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041606"
FT   VARIANT         1190
FT                   /note="L -> V (in dbSNP:rs34598508)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041607"
FT   VARIANT         1237
FT                   /note="A -> T (in dbSNP:rs191531119)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041608"
FT   VARIANT         1279
FT                   /note="L -> F"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041609"
FT   VARIANT         1314
FT                   /note="G -> V (in dbSNP:rs8178090)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019185"
FT   VARIANT         1447
FT                   /note="R -> M (in a lung squamous cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041610"
FT   VARIANT         1588
FT                   /note="D -> V (in dbSNP:rs8178104)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019186"
FT   VARIANT         1603
FT                   /note="Q -> H (in dbSNP:rs8178106)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019187"
FT   VARIANT         1619
FT                   /note="A -> G (in dbSNP:rs56182356)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041611"
FT   VARIANT         1680
FT                   /note="A -> V (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs55735910)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041612"
FT   VARIANT         2023
FT                   /note="S -> P (in dbSNP:rs56042895)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041613"
FT   VARIANT         2095
FT                   /note="A -> V (in dbSNP:rs8178147)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019188"
FT   VARIANT         2598
FT                   /note="R -> Q (in dbSNP:rs55923149)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041614"
FT   VARIANT         2702
FT                   /note="K -> E (in dbSNP:rs8178178)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019189"
FT   VARIANT         2810
FT                   /note="S -> N (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041615"
FT   VARIANT         2899
FT                   /note="R -> C (in dbSNP:rs4278157)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019190"
FT   VARIANT         2941
FT                   /note="G -> A (in a lung neuroendocrine carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041616"
FT   VARIANT         3062
FT                   /note="L -> R (in IMD26; shows increased long palindromic
FT                   (P)-nucleotide stretches in the immunoglobulin coding
FT                   joints indicating a defect in hairpin opening and
FT                   insufficient DCLRE1C activation; dbSNP:rs587777685)"
FT                   /evidence="ECO:0000269|PubMed:19075392"
FT                   /id="VAR_072569"
FT   VARIANT         3085
FT                   /note="E -> D (in dbSNP:rs56135402)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041617"
FT   VARIANT         3149
FT                   /note="G -> D (in dbSNP:rs8178208)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019191"
FT   VARIANT         3198
FT                   /note="T -> S (in dbSNP:rs55793951)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041618"
FT   VARIANT         3201
FT                   /note="P -> S (in dbSNP:rs8178216)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019192"
FT   VARIANT         3404
FT                   /note="G -> E (in dbSNP:rs8178225)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019193"
FT   VARIANT         3434
FT                   /note="I -> T (in dbSNP:rs7830743)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019194"
FT   VARIANT         3459
FT                   /note="N -> S (in dbSNP:rs8178228)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019195"
FT   VARIANT         3562
FT                   /note="L -> M (in dbSNP:rs8178232)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019196"
FT   VARIANT         3574
FT                   /note="A -> V (in IMD26; shows impaired function in
FT                   response to irradiation and a less severe defect in V(D)J
FT                   end-joining suggesting that the missense mutation retained
FT                   some functional capacity; consistent with a loss of
FT                   function mutation; dbSNP:rs587777686)"
FT                   /evidence="ECO:0000269|PubMed:23722905"
FT                   /id="VAR_072570"
FT   VARIANT         3584
FT                   /note="L -> F (in dbSNP:rs55866966)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041619"
FT   VARIANT         3702
FT                   /note="P -> L (in dbSNP:rs8178236)"
FT                   /id="VAR_050534"
FT   VARIANT         3800
FT                   /note="L -> I (in dbSNP:rs56216442)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041620"
FT   VARIANT         3836
FT                   /note="P -> L (in dbSNP:rs8178245)"
FT                   /evidence="ECO:0000269|PubMed:17344846, ECO:0000269|Ref.3"
FT                   /id="VAR_019197"
FT   VARIANT         3932
FT                   /note="M -> V (in dbSNP:rs8178248)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_019198"
FT   VARIANT         3936
FT                   /note="G -> S (in dbSNP:rs55670423)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041621"
FT   VARIANT         3937
FT                   /note="V -> M (in dbSNP:rs56090750)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041622"
FT   MUTAGEN         1510
FT                   /note="L->P: Loss of interaction with C1D."
FT                   /evidence="ECO:0000269|PubMed:9679063"
FT   MUTAGEN         1516..1517
FT                   /note="EL->PD: Loss of interaction with C1D."
FT                   /evidence="ECO:0000269|PubMed:9679063"
FT   MUTAGEN         2609
FT                   /note="T->A: Leads to radiation sensitivity and impaired
FT                   DSB joining. Gives rise to reduced phosphorylation; when
FT                   associated with A-2612."
FT                   /evidence="ECO:0000269|PubMed:12231622"
FT   MUTAGEN         2612
FT                   /note="S->A: Reduced phosphorylation; when associated with
FT                   A-2609."
FT   MUTAGEN         2638
FT                   /note="T->A: Alleviates phosphorylation, leaves a fully
FT                   active enzyme with compromised cellular resistance to
FT                   ionizing radiation without affecting DNA end joining; when
FT                   associated with A-2647."
FT                   /evidence="ECO:0000269|PubMed:12649176"
FT   MUTAGEN         2647
FT                   /note="T->A: Alleviates phosphorylation, leaves a fully
FT                   active enzyme with compromised cellular resistance to
FT                   ionizing radiation without affecting DNA end joining; when
FT                   associated with A-2638."
FT                   /evidence="ECO:0000269|PubMed:12649176"
FT   CONFLICT        405
FT                   /note="D -> Y (in Ref. 2; AAC50210)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1008
FT                   /note="A -> S (in Ref. 2; AAC50210)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3660
FT                   /note="N -> T (in Ref. 8; AAA79184)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3817
FT                   /note="L -> W (in Ref. 8; AAA79184)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3862
FT                   /note="A -> P (in Ref. 8; AAA79184)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        4031
FT                   /note="I -> V (in Ref. 9; AAK40350)"
FT                   /evidence="ECO:0000305"
FT   HELIX           12..22
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            24..26
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   TURN            28..30
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          31..33
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           35..44
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           50..52
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           54..57
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           59..62
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           64..70
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           76..96
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:6ZFP"
FT   STRAND          101..103
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           104..115
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           121..123
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           129..145
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            148..150
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           154..161
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            162..164
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   STRAND          165..167
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           174..177
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           180..184
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           186..189
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           192..206
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          211..213
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           218..222
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           224..231
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          232..234
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   TURN            238..240
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           243..254
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          255..257
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            258..260
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           267..277
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            279..281
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   STRAND          282..284
FT                   /evidence="ECO:0007829|PDB:7OTM"
FT   HELIX           285..288
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           290..301
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           308..329
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          331..333
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           335..350
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           357..368
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           371..376
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:6ZFP"
FT   HELIX           380..395
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            396..398
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   STRAND          401..404
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           407..409
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           410..423
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           429..431
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           432..444
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           446..448
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   TURN            451..453
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           454..468
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            469..471
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           473..492
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          505..507
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   STRAND          513..518
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           525..527
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           528..534
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           540..544
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           545..547
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   STRAND          552..554
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           560..577
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          583..585
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            608..611
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          612..616
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           617..633
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            634..636
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           639..642
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           643..645
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           646..659
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           664..678
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            679..685
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           698..717
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           718..720
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           725..733
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           738..758
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            759..761
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           763..779
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           782..785
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           786..788
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           789..792
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           793..795
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           797..799
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            800..804
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           815..821
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           828..837
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   HELIX           848..861
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            864..866
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           867..872
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           873..876
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            877..879
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           881..883
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   STRAND          886..889
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          893..895
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          904..907
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           908..910
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           911..920
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          923..925
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           926..944
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          950..952
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           959..973
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           978..996
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1000..1002
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   TURN            1003..1007
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1008..1014
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1015..1017
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1019..1021
FT                   /evidence="ECO:0007829|PDB:6ZFP"
FT   HELIX           1024..1043
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1046..1049
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1056..1067
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1072..1085
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1086..1091
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1093..1113
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1114..1116
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1119..1121
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           1123..1140
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1142..1145
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1165..1174
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1175..1177
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1181..1194
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1195..1197
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1198..1200
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           1204..1214
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1218..1225
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1228..1232
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   TURN            1235..1237
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1239..1243
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1245..1247
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   STRAND          1248..1250
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           1253..1272
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1274..1276
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1278..1281
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1282..1286
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1290..1298
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1300..1303
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1309..1311
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1317..1319
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   TURN            1324..1326
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1327..1350
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1355..1358
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1359..1362
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1365..1377
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1379..1382
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1391..1408
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1409..1411
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           1412..1420
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1425..1432
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1437..1440
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1442..1461
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1464..1467
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1472..1475
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1477..1480
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1482..1486
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1488..1490
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1494..1496
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1504..1506
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1507..1519
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1521..1523
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1525..1532
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1555..1573
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1575..1584
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1585..1589
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1592..1606
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1607..1610
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   HELIX           1612..1624
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1626..1629
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1630..1632
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1634..1637
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           1639..1655
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1658..1660
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1662..1667
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1668..1679
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1682..1684
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           1686..1692
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1693..1695
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           1696..1698
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1699..1701
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   TURN            1703..1706
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1707..1721
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1724..1726
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1734..1753
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1756..1766
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1769..1771
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1775..1785
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1786..1788
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1791..1805
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1814..1821
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1824..1828
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1832..1834
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1835..1852
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1856..1861
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           1863..1881
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1882..1884
FT                   /evidence="ECO:0007829|PDB:6ZFP"
FT   HELIX           1886..1889
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1890..1893
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1894..1897
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   TURN            1899..1901
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1906..1908
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           1911..1924
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1931..1933
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1934..1955
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1959..1966
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   STRAND          1967..1969
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           1971..1973
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          1974..1976
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            1978..1980
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   STRAND          1984..1986
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   STRAND          1992..1996
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   HELIX           1999..2013
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           2026..2028
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           2036..2044
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   STRAND          2087..2090
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          2091..2093
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   HELIX           2094..2105
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2124..2134
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2140..2152
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            2153..2157
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2158..2160
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           2161..2171
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          2173..2182
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2184..2195
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            2196..2199
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2206..2221
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2228..2244
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            2245..2248
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2255..2260
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2269..2282
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          2292..2294
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           2297..2305
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2306..2308
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2313..2332
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          2335..2337
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           2338..2353
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            2354..2356
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           2358..2368
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2372..2377
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2379..2385
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2386..2388
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2392..2403
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          2404..2407
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2413..2417
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2420..2424
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2430..2442
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2443..2445
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2448..2458
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2459..2461
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   STRAND          2467..2469
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2470..2483
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          2487..2490
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   STRAND          2492..2494
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           2495..2508
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2509..2511
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2515..2525
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            2528..2530
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2535..2543
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2548..2550
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2551..2563
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2564..2567
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   TURN            2570..2573
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2581..2583
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           2594..2602
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   STRAND          2634..2636
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   STRAND          2658..2660
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   STRAND          2721..2723
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   HELIX           2736..2763
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   TURN            2764..2766
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   STRAND          2772..2774
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   TURN            2777..2779
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           2788..2798
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2802..2823
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2826..2846
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2852..2864
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          2868..2871
FT                   /evidence="ECO:0007829|PDB:7K11"
FT   HELIX           2873..2883
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2886..2898
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2918..2932
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2936..2946
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2952..2961
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2965..2976
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          2982..2984
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           2988..3004
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3008..3013
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3014..3016
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3019..3024
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3027..3031
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3032..3036
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3038..3040
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3041..3054
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3060..3069
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3072..3074
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3075..3079
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3083..3092
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3096..3116
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3122..3130
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3133..3145
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3147..3149
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   STRAND          3151..3153
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3154..3166
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3171..3173
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3176..3193
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3194..3196
FT                   /evidence="ECO:0007829|PDB:7OTM"
FT   TURN            3227..3229
FT                   /evidence="ECO:0007829|PDB:6ZFP"
FT   HELIX           3231..3248
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3252..3260
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3263..3265
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   STRAND          3266..3271
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3272..3286
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3288..3290
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   TURN            3291..3293
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3294..3306
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3308..3310
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   TURN            3314..3316
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3319..3322
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3323..3343
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3346..3351
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3354..3363
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3364..3366
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3370..3392
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3403..3405
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           3407..3428
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3434..3439
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   HELIX           3442..3455
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3459..3462
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3465..3471
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3472..3474
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   HELIX           3476..3479
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3481..3487
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3488..3490
FT                   /evidence="ECO:0007829|PDB:7K11"
FT   HELIX           3494..3498
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3499..3505
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3507..3510
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3512..3514
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3515..3524
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3526..3528
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           3530..3537
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3545..3547
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3548..3562
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3564..3566
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           3567..3575
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3576..3578
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3581..3593
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3595..3599
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3602..3604
FT                   /evidence="ECO:0007829|PDB:7K10"
FT   TURN            3605..3608
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3609..3616
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3617..3619
FT                   /evidence="ECO:0007829|PDB:7K11"
FT   HELIX           3621..3626
FT                   /evidence="ECO:0007829|PDB:7K11"
FT   HELIX           3627..3635
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3636..3639
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3640..3643
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3647..3649
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3650..3652
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           3658..3670
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3671..3673
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3681..3683
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3687..3689
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3694..3696
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   STRAND          3707..3711
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3713..3715
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   STRAND          3718..3722
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3730..3733
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3736..3742
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3743..3745
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3746..3752
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3759..3777
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3779..3783
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3793..3797
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3800..3804
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3807..3811
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3812..3817
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3822..3829
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3835..3845
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3847..3849
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3854..3861
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3864..3875
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3876..3878
FT                   /evidence="ECO:0007829|PDB:7K11"
FT   HELIX           3882..3889
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3890..3893
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           3894..3918
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3927..3931
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3932..3934
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3937..3939
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3945..3947
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   HELIX           3948..3951
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          3952..3955
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   STRAND          3959..3961
FT                   /evidence="ECO:0007829|PDB:6ZFP"
FT   HELIX           3965..3970
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            3971..3973
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   TURN            3976..3978
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3979..3993
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           3995..4007
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           4009..4011
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           4013..4021
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           4027..4029
FT                   /evidence="ECO:0007829|PDB:7SU3"
FT   STRAND          4030..4032
FT                   /evidence="ECO:0007829|PDB:7SGL"
FT   HELIX           4034..4036
FT                   /evidence="ECO:0007829|PDB:7K11"
FT   HELIX           4041..4050
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            4051..4053
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           4056..4067
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          4068..4070
FT                   /evidence="ECO:0007829|PDB:7OTW"
FT   HELIX           4074..4082
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   TURN            4085..4087
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          4091..4093
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   STRAND          4095..4097
FT                   /evidence="ECO:0007829|PDB:7K11"
FT   HELIX           4100..4112
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           4114..4117
FT                   /evidence="ECO:0007829|PDB:7OTY"
FT   HELIX           4122..4124
FT                   /evidence="ECO:0007829|PDB:7OTW"
SQ   SEQUENCE   4128 AA;  469089 MW;  AC6E747FEB09F3E5 CRC64;
     MAGSGAGVRC SLLRLQETLS AADRCGAALA GHQLIRGLGQ ECVLSSSPAV LALQTSLVFS
     RDFGLLVFVR KSLNSIEFRE CREEILKFLC IFLEKMGQKI APYSVEIKNT CTSVYTKDRA
     AKCKIPALDL LIKLLQTFRS SRLMDEFKIG ELFSKFYGEL ALKKKIPDTV LEKVYELLGL
     LGEVHPSEMI NNAENLFRAF LGELKTQMTS AVREPKLPVL AGCLKGLSSL LCNFTKSMEE
     DPQTSREIFN FVLKAIRPQI DLKRYAVPSA GLRLFALHAS QFSTCLLDNY VSLFEVLLKW
     CAHTNVELKK AALSALESFL KQVSNMVAKN AEMHKNKLQY FMEQFYGIIR NVDSNNKELS
     IAIRGYGLFA GPCKVINAKD VDFMYVELIQ RCKQMFLTQT DTGDDRVYQM PSFLQSVASV
     LLYLDTVPEV YTPVLEHLVV MQIDSFPQYS PKMQLVCCRA IVKVFLALAA KGPVLRNCIS
     TVVHQGLIRI CSKPVVLPKG PESESEDHRA SGEVRTGKWK VPTYKDYVDL FRHLLSSDQM
     MDSILADEAF FSVNSSSESL NHLLYDEFVK SVLKIVEKLD LTLEIQTVGE QENGDEAPGV
     WMIPTSDPAA NLHPAKPKDF SAFINLVEFC REILPEKQAE FFEPWVYSFS YELILQSTRL
     PLISGFYKLL SITVRNAKKI KYFEGVSPKS LKHSPEDPEK YSCFALFVKF GKEVAVKMKQ
     YKDELLASCL TFLLSLPHNI IELDVRAYVP ALQMAFKLGL SYTPLAEVGL NALEEWSIYI
     DRHVMQPYYK DILPCLDGYL KTSALSDETK NNWEVSALSR AAQKGFNKVV LKHLKKTKNL
     SSNEAISLEE IRIRVVQMLG SLGGQINKNL LTVTSSDEMM KSYVAWDREK RLSFAVPFRE
     MKPVIFLDVF LPRVTELALT ASDRQTKVAA CELLHSMVMF MLGKATQMPE GGQGAPPMYQ
     LYKRTFPVLL RLACDVDQVT RQLYEPLVMQ LIHWFTNNKK FESQDTVALL EAILDGIVDP
     VDSTLRDFCG RCIREFLKWS IKQITPQQQE KSPVNTKSLF KRLYSLALHP NAFKRLGASL
     AFNNIYREFR EEESLVEQFV FEALVIYMES LALAHADEKS LGTIQQCCDA IDHLCRIIEK
     KHVSLNKAKK RRLPRGFPPS ASLCLLDLVK WLLAHCGRPQ TECRHKSIEL FYKFVPLLPG
     NRSPNLWLKD VLKEEGVSFL INTFEGGGCG QPSGILAQPT LLYLRGPFSL QATLCWLDLL
     LAALECYNTF IGERTVGALQ VLGTEAQSSL LKAVAFFLES IAMHDIIAAE KCFGTGAAGN
     RTSPQEGERY NYSKCTVVVR IMEFTTTLLN TSPEGWKLLK KDLCNTHLMR VLVQTLCEPA
     SIGFNIGDVQ VMAHLPDVCV NLMKALKMSP YKDILETHLR EKITAQSIEE LCAVNLYGPD
     AQVDRSRLAA VVSACKQLHR AGLLHNILPS QSTDLHHSVG TELLSLVYKG IAPGDERQCL
     PSLDLSCKQL ASGLLELAFA FGGLCERLVS LLLNPAVLST ASLGSSQGSV IHFSHGEYFY
     SLFSETINTE LLKNLDLAVL ELMQSSVDNT KMVSAVLNGM LDQSFRERAN QKHQGLKLAT
     TILQHWKKCD SWWAKDSPLE TKMAVLALLA KILQIDSSVS FNTSHGSFPE VFTTYISLLA
     DTKLDLHLKG QAVTLLPFFT SLTGGSLEEL RRVLEQLIVA HFPMQSREFP PGTPRFNNYV
     DCMKKFLDAL ELSQSPMLLE LMTEVLCREQ QHVMEELFQS SFRRIARRGS CVTQVGLLES
     VYEMFRKDDP RLSFTRQSFV DRSLLTLLWH CSLDALREFF STIVVDAIDV LKSRFTKLNE
     STFDTQITKK MGYYKILDVM YSRLPKDDVH AKESKINQVF HGSCITEGNE LTKTLIKLCY
     DAFTENMAGE NQLLERRRLY HCAAYNCAIS VICCVFNELK FYQGFLFSEK PEKNLLIFEN
     LIDLKRRYNF PVEVEVPMER KKKYIEIRKE AREAANGDSD GPSYMSSLSY LADSTLSEEM
     SQFDFSTGVQ SYSYSSQDPR PATGRFRRRE QRDPTVHDDV LELEMDELNR HECMAPLTAL
     VKHMHRSLGP PQGEEDSVPR DLPSWMKFLH GKLGNPIVPL NIRLFLAKLV INTEEVFRPY
     AKHWLSPLLQ LAASENNGGE GIHYMVVEIV ATILSWTGLA TPTGVPKDEV LANRLLNFLM
     KHVFHPKRAV FRHNLEIIKT LVECWKDCLS IPYRLIFEKF SGKDPNSKDN SVGIQLLGIV
     MANDLPPYDP QCGIQSSEYF QALVNNMSFV RYKEVYAAAA EVLGLILRYV MERKNILEES
     LCELVAKQLK QHQNTMEDKF IVCLNKVTKS FPPLADRFMN AVFFLLPKFH GVLKTLCLEV
     VLCRVEGMTE LYFQLKSKDF VQVMRHRDDE RQKVCLDIIY KMMPKLKPVE LRELLNPVVE
     FVSHPSTTCR EQMYNILMWI HDNYRDPESE TDNDSQEIFK LAKDVLIQGL IDENPGLQLI
     IRNFWSHETR LPSNTLDRLL ALNSLYSPKI EVHFLSLATN FLLEMTSMSP DYPNPMFEHP
     LSECEFQEYT IDSDWRFRST VLTPMFVETQ ASQGTLQTRT QEGSLSARWP VAGQIRATQQ
     QHDFTLTQTA DGRSSFDWLT GSSTDPLVDH TSPSSDSLLF AHKRSERLQR APLKSVGPDF
     GKKRLGLPGD EVDNKVKGAA GRTDLLRLRR RFMRDQEKLS LMYARKGVAE QKREKEIKSE
     LKMKQDAQVV LYRSYRHGDL PDIQIKHSSL ITPLQAVAQR DPIIAKQLFS SLFSGILKEM
     DKFKTLSEKN NITQKLLQDF NRFLNTTFSF FPPFVSCIQD ISCQHAALLS LDPAAVSAGC
     LASLQQPVGI RLLEEALLRL LPAELPAKRV RGKARLPPDV LRWVELAKLY RSIGEYDVLR
     GIFTSEIGTK QITQSALLAE ARSDYSEAAK QYDEALNKQD WVDGEPTEAE KDFWELASLD
     CYNHLAEWKS LEYCSTASID SENPPDLNKI WSEPFYQETY LPYMIRSKLK LLLQGEADQS
     LLTFIDKAMH GELQKAILEL HYSQELSLLY LLQDDVDRAK YYIQNGIQSF MQNYSSIDVL
     LHQSRLTKLQ SVQALTEIQE FISFISKQGN LSSQVPLKRL LNTWTNRYPD AKMDPMNIWD
     DIITNRCFFL SKIEEKLTPL PEDNSMNVDQ DGDPSDRMEV QEQEEDISSL IRSCKFSMKM
     KMIDSARKQN NFSLAMKLLK ELHKESKTRD DWLVSWVQSY CRLSHCRSRS QGCSEQVLTV
     LKTVSLLDEN NVSSYLSKNI LAFRDQNILL GTTYRIIANA LSSEPACLAE IEEDKARRIL
     ELSGSSSEDS EKVIAGLYQR AFQHLSEAVQ AAEEEAQPPS WSCGPAAGVI DAYMTLADFC
     DQQLRKEEEN ASVIDSAELQ AYPALVVEKM LKALKLNSNE ARLKFPRLLQ IIERYPEETL
     SLMTKEISSV PCWQFISWIS HMVALLDKDQ AVAVQHSVEE ITDNYPQAIV YPFIISSESY
     SFKDTSTGHK NKEFVARIKS KLDQGGVIQD FINALDQLSN PELLFKDWSN DVRAELAKTP
     VNKKNIEKMY ERMYAALGDP KAPGLGAFRR KFIQTFGKEF DKHFGKGGSK LLRMKLSDFN
     DITNMLLLKM NKDSKPPGNL KECSPWMSDF KVEFLRNELE IPGQYDGRGK PLPEYHVRIA
     GFDERVTVMA SLRRPKRIII RGHDEREHPF LVKGGEDLRQ DQRVEQLFQV MNGILAQDSA
     CSQRALQLRT YSVVPMTSRL GLIEWLENTV TLKDLLLNTM SQEEKAAYLS DPRAPPCEYK
     DWLTKMSGKH DVGAYMLMYK GANRTETVTS FRKRESKVPA DLLKRAFVRM STSPEAFLAL
     RSHFASSHAL ICISHWILGI GDRHLNNFMV AMETGGVIGI DFGHAFGSAT QFLPVPELMP
     FRLTRQFINL MLPMKETGLM YSIMVHALRA FRSDPGLLTN TMDVFVKEPS FDWKNFEQKM
     LKKGGSWIQE INVAEKNWYP RQKICYAKRK LAGANPAVIT CDELLLGHEK APAFRDYVAV
     ARGSKDHNIR AQEPESGLSE ETQVKCLMDQ ATDPNILGRT WEGWEPWM
//
